<main class="publication" lang="en" role="main">
      


<div class="govuk-grid-row">
  <div class="govuk-grid-column-two-thirds">
    

<div class="gem-c-title govuk-!-margin-top-8 govuk-!-margin-bottom-8">
      <span class="govuk-caption-xl gem-c-title__context">
    Decision
  </span>


  <h1 class="gem-c-title__text govuk-heading-l">
    Regulatory approval of COVID-19 vaccine Nuvaxovid
  </h1>
</div>
  </div>
  

  <div class="govuk-grid-column-two-thirds">
    
  <p class="gem-c-lead-paragraph">Information for healthcare professionals and the public about the COVID-19 vaccine Nuvaxovid.</p>

  </div>
</div>

<div class="govuk-grid-row">
  <div class="metadata-logo-wrapper">
    <div class="govuk-grid-column-two-thirds metadata-column">
      <div data-module="gem-toggle metadata" class="gem-c-metadata">
  <dl data-module="gem-track-click">
      <dt class="gem-c-metadata__term">From:</dt>
      <dd class="gem-c-metadata__definition">
          <a href="/government/organisations/medicines-and-healthcare-products-regulatory-agency" class="govuk-link">Medicines and Healthcare products Regulatory Agency</a>

      </dd>
      <dt class="gem-c-metadata__term">Published</dt>
      <dd class="gem-c-metadata__definition">3 February 2022</dd>
  </dl>
</div>
    </div>
    <div class="govuk-grid-column-one-third">
    </div>
  </div>
</div>








<div class="govuk-grid-row">
  <div class="govuk-grid-column-two-thirds">
    <div class="responsive-bottom-margin">
      

      <div class="responsive-bottom-margin">
          <section>
    <h2 class="gem-c-heading gem-c-heading--font-size-27 gem-c-heading--mobile-top-margin">Documents</h2>


      
<div class="gem-c-govspeak govuk-govspeak direction-ltr" data-module="govspeak">
    
        <section class="attachment embedded">
  <div class="attachment-thumb">
      <a tabindex="-1" class="thumbnail" href="/government/publications/regulatory-approval-of-covid-19-vaccine-nuvaxovid/summary-of-product-characteristics-for-nuvaxovid-dispersion-for-injection"><img alt="" src="https://www.gov.uk/assets/whitehall/pub-cover-html-b0465911e56983d98c70f0e25fba24bc206d37e8c83d4addf6421dcf6022c6cd.png"></a>
  </div>
  <div class="attachment-details">
    <h3 class="title govuk-!-font-size-27 govuk-!-font-weight-regular"><a class="govuk-link" href="/government/publications/regulatory-approval-of-covid-19-vaccine-nuvaxovid/summary-of-product-characteristics-for-nuvaxovid-dispersion-for-injection">Summary of Product Characteristics for Nuvaxovid dispersion for injection</a></h3>
    <p class="govuk-body metadata">
        <span class="type">HTML</span>
    </p>


  </div>
</section><section class="attachment embedded">
  <div class="attachment-thumb">
      <a href="https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1052236/Nuvaxovid_GB_SmPC.pdf" class="thumbnail" tabindex="-1"><img src="https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1052236/thumbnail_Nuvaxovid_GB_SmPC.pdf.png" alt=""></a>
  </div>
  <div class="attachment-details">
    <h3 class="title govuk-!-font-size-27 govuk-!-font-weight-regular"><a aria-describedby="attachment-6381249-accessibility-help" class="govuk-link" href="https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1052236/Nuvaxovid_GB_SmPC.pdf">Summary of Product Characteristics for Nuvaxovid dispersion for injection</a></h3>
    <p class="govuk-body metadata">
        <span class="type"><abbr title="Portable Document Format">PDF</abbr></span>, <span class="file-size">249 KB</span>, <span class="page-length" lang="en">12 pages</span>
    </p>


      <div class="accessibility-warning" data-module="toggle">
        <p class="govuk-body">This file may not be suitable for users of assistive technology.</p>
        <details class="gem-c-details govuk-details govuk-!-margin-bottom-3" data-module="govuk-details gem-details">
  <summary data-details-track-click="" data-track-category="Accessible Format Request" data-track-label="Summary of Product Characteristics for Nuvaxovid dispersion for injection" class="govuk-details__summary" data-track-action="FormatRequestClicked" data-module="govuk-details">
    <span class="govuk-details__summary-text">
      Request an accessible format.
    </span>
</summary>  <div class="govuk-details__text">
    
          If you use assistive technology (such as a screen reader) and need a
version of this document in a more accessible format, please email <a href="mailto:webupdates@mhra.gov.uk?body=Details%20of%20document%20required%3A%0A%0A%20%20Title%3A%20Summary%20of%20Product%20Characteristics%20for%20Nuvaxovid%20dispersion%20for%20injection%0A%20%20Original%20format%3A%20pdf%0A%0APlease%20tell%20us%3A%0A%0A%20%201.%20What%20makes%20this%20format%20unsuitable%20for%20you%3F%0A%20%202.%20What%20format%20you%20would%20prefer%3F%0A%20%20%20%20%20%20&amp;subject=Request%20for%20%27Summary%20of%20Product%20Characteristics%20for%20Nuvaxovid%20dispersion%20for%20injection%27%20in%20an%20alternative%20format">webupdates@mhra.gov.uk</a>.
Please tell us what format you need. It will help us if you say what assistive technology you use.


  </div>
</details>      </div>
  </div>
</section><section class="attachment embedded">
  <div class="attachment-thumb">
      <a tabindex="-1" href="/government/publications/regulatory-approval-of-covid-19-vaccine-nuvaxovid/product-information-leaflet-pil-for-nuvaxovid-dispersion-for-injection" class="thumbnail"><img alt="" src="https://www.gov.uk/assets/whitehall/pub-cover-html-b0465911e56983d98c70f0e25fba24bc206d37e8c83d4addf6421dcf6022c6cd.png"></a>
  </div>
  <div class="attachment-details">
    <h3 class="title govuk-!-font-size-27 govuk-!-font-weight-regular"><a class="govuk-link" href="/government/publications/regulatory-approval-of-covid-19-vaccine-nuvaxovid/product-information-leaflet-pil-for-nuvaxovid-dispersion-for-injection">Product Information Leaflet (PIL) for Nuvaxovid dispersion for injection</a></h3>
    <p class="govuk-body metadata">
        <span class="type">HTML</span>
    </p>


  </div>
</section><section class="attachment embedded">
  <div class="attachment-thumb">
      <a tabindex="-1" class="thumbnail" href="https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1052237/Nuvaxovid_GB_PIL.pdf"><img src="https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1052237/thumbnail_Nuvaxovid_GB_PIL.pdf.png" alt=""></a>
  </div>
  <div class="attachment-details">
    <h3 class="title govuk-!-font-size-27 govuk-!-font-weight-regular"><a aria-describedby="attachment-6381250-accessibility-help" class="govuk-link" href="https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1052237/Nuvaxovid_GB_PIL.pdf">Product Information Leaflet (PIL) for Nuvaxovid dispersion for injection</a></h3>
    <p class="govuk-body metadata">
        <span class="type"><abbr title="Portable Document Format">PDF</abbr></span>, <span class="file-size">126 KB</span>, <span class="page-length" lang="en">6 pages</span>
    </p>


      <div class="accessibility-warning" data-module="toggle">
        <p class="govuk-body">This file may not be suitable for users of assistive technology.</p>
        <details data-module="govuk-details gem-details" class="gem-c-details govuk-details govuk-!-margin-bottom-3">
  <summary data-details-track-click="" class="govuk-details__summary" data-track-category="Accessible Format Request" data-track-action="FormatRequestClicked" data-track-label="Product Information Leaflet (PIL) for Nuvaxovid dispersion for injection" data-module="govuk-details">
    <span class="govuk-details__summary-text">
      Request an accessible format.
    </span>
</summary>  <div class="govuk-details__text">
    
          If you use assistive technology (such as a screen reader) and need a
version of this document in a more accessible format, please email <a href="mailto:webupdates@mhra.gov.uk?body=Details%20of%20document%20required%3A%0A%0A%20%20Title%3A%20Product%20Information%20Leaflet%20%28PIL%29%20for%20Nuvaxovid%20dispersion%20for%20injection%0A%20%20Original%20format%3A%20pdf%0A%0APlease%20tell%20us%3A%0A%0A%20%201.%20What%20makes%20this%20format%20unsuitable%20for%20you%3F%0A%20%202.%20What%20format%20you%20would%20prefer%3F%0A%20%20%20%20%20%20&amp;subject=Request%20for%20%27Product%20Information%20Leaflet%20%28PIL%29%20for%20Nuvaxovid%20dispersion%20for%20injection%27%20in%20an%20alternative%20format">webupdates@mhra.gov.uk</a>.
Please tell us what format you need. It will help us if you say what assistive technology you use.


  </div>
</details>      </div>
  </div>
</section><section class="attachment embedded">
  <div class="attachment-thumb">
      <a tabindex="-1" class="thumbnail" href="/government/publications/regulatory-approval-of-covid-19-vaccine-nuvaxovid/conditional-marketing-authorisation-conditions-for-nuvaxovid-dispersion-for-injection"><img src="https://www.gov.uk/assets/whitehall/pub-cover-html-b0465911e56983d98c70f0e25fba24bc206d37e8c83d4addf6421dcf6022c6cd.png" alt=""></a>
  </div>
  <div class="attachment-details">
    <h3 class="title govuk-!-font-size-27 govuk-!-font-weight-regular"><a href="/government/publications/regulatory-approval-of-covid-19-vaccine-nuvaxovid/conditional-marketing-authorisation-conditions-for-nuvaxovid-dispersion-for-injection" class="govuk-link">Conditional Marketing Authorisation conditions for Nuvaxovid dispersion for injection </a></h3>
    <p class="govuk-body metadata">
        <span class="type">HTML</span>
    </p>


  </div>
</section><section class="attachment embedded">
  <div class="attachment-thumb">
      <a href="https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1052238/Nuvaxovid_GB_CMA_Conditions.pdf" class="thumbnail" tabindex="-1"><img src="https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1052238/thumbnail_Nuvaxovid_GB_CMA_Conditions.pdf.png" alt=""></a>
  </div>
  <div class="attachment-details">
    <h3 class="title govuk-!-font-size-27 govuk-!-font-weight-regular"><a aria-describedby="attachment-6381289-accessibility-help" href="https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1052238/Nuvaxovid_GB_CMA_Conditions.pdf" class="govuk-link">Conditional Marketing Authorisation conditions for Nuvaxovid dispersion for injection</a></h3>
    <p class="govuk-body metadata">
        <span class="type"><abbr title="Portable Document Format">PDF</abbr></span>, <span class="file-size">109 KB</span>, <span class="page-length" lang="en">1 page</span>
    </p>


      <div data-module="toggle" class="accessibility-warning">
        <p class="govuk-body">This file may not be suitable for users of assistive technology.</p>
        <details data-module="govuk-details gem-details" class="gem-c-details govuk-details govuk-!-margin-bottom-3">
  <summary data-track-category="Accessible Format Request" data-track-action="FormatRequestClicked" data-track-label="Conditional Marketing Authorisation conditions for Nuvaxovid dispersion for injection" class="govuk-details__summary" data-module="govuk-details" data-details-track-click="">
    <span class="govuk-details__summary-text">
      Request an accessible format.
    </span>
</summary>  <div class="govuk-details__text">
    
          If you use assistive technology (such as a screen reader) and need a
version of this document in a more accessible format, please email <a href="mailto:webupdates@mhra.gov.uk?body=Details%20of%20document%20required%3A%0A%0A%20%20Title%3A%20Conditional%20Marketing%20Authorisation%20conditions%20for%20Nuvaxovid%20dispersion%20for%20injection%0A%20%20Original%20format%3A%20pdf%0A%0APlease%20tell%20us%3A%0A%0A%20%201.%20What%20makes%20this%20format%20unsuitable%20for%20you%3F%0A%20%202.%20What%20format%20you%20would%20prefer%3F%0A%20%20%20%20%20%20&amp;subject=Request%20for%20%27Conditional%20Marketing%20Authorisation%20conditions%20for%20Nuvaxovid%20dispersion%20for%20injection%27%20in%20an%20alternative%20format">webupdates@mhra.gov.uk</a>.
Please tell us what format you need. It will help us if you say what assistive technology you use.


  </div>
</details>      </div>
  </div>
</section>

</div>
  </section>


        <section>
          <h2 class="gem-c-heading gem-c-heading--font-size-27 gem-c-heading--mobile-top-margin">Details</h2>


          
<div class="gem-c-govspeak govuk-govspeak direction-ltr" data-module="govspeak">
    
            <div class="govspeak">
<p>Information about the COVID-19 vaccine Nuvaxovid, approved by the MHRA on 03 February 2022.</p>

<p>The Summary of Product Characteristics is a description of a medicinal product’s properties and the conditions attached to its use. It explains how to use and prescribe a medicine. It is used by healthcare professionals, such as doctors, nurses and pharmacists.</p>

<p>The Patient Information Leaflet provides information for patients on using the medicine safely. This is based on the Summary of Product Characteristics of the product.</p>

<p>The Conditional Marketing Authorisation (CMA) granted by the MHRA is valid in Great Britain only. Nuvaxovid is authorised in Northern Ireland under the CMA granted by the European Medicines Agency on 20 December 2021. This CMA has similar requirements to that granted by the MHRA.</p>

<p>See <a class="govuk-link" href="https://www.gov.uk/government/news/novavax-covid-19-vaccine-nuvaxovid-approved-by-mhra">further information in our press release</a>.</p>

<h2>Ingredients</h2>

<p>The MHRA can confirm that Nuvaxovid does not contain any components of animal origin.</p>

<p>A full list of ingredients for the qualitative and quantitative composition of the vaccine can be found at point 2 in the <a href="https://www.gov.uk/government/publications/regulatory-approval-of-covid-19-vaccine-nuvaxovid/summary-of-product-characteristics-for-nuvaxovid-dispersion-for-injection#qualitative-and-quantitative-composition" class="govuk-link">Summary of Product Characteristics for COVID-19 vaccine Nuvaxovid</a>.</p>

<p>A full list of ingredients for the excipient composition of the vaccine can be found at point 6.1 in the <a href="https://www.gov.uk/government/publications/regulatory-approval-of-covid-19-vaccine-nuvaxovid/summary-of-product-characteristics-for-nuvaxovid-dispersion-for-injection#pharmaceutical-particulars" class="govuk-link">Summary of Product Characteristics for COVID-19 vaccine Nuvaxovid</a>.</p>

<p>A full list of ingredients for the qualitative and quantitative composition of the vaccine and a full list of the excipient composition of the vaccine can be found at point 6 in the <a href="https://www.gov.uk/government/publications/regulatory-approval-of-covid-19-vaccine-nuvaxovid/product-information-leaflet-pil-for-nuvaxovid-dispersion-for-injection#contents-of-the-pack-and-other-information" class="govuk-link">Patient Information Leaflet for COVID-19 vaccine Nuvaxovid</a>.</p>
</div>

</div>
        </section>
      </div>
      
<div class="app-c-published-dates govuk-!-margin-bottom-3" lang="en">
    Published 3 February 2022
</div>



    </div>
  </div>
  
<div class="govuk-grid-column-one-third">
  


</div>

</div>


  <div class="govuk-grid-row">
    <div class="govuk-grid-column-two-thirds">
        
  <div class="gem-c-contextual-footer">
    
  <div class="gem-c-related-navigation">





      <nav class="gem-c-related-navigation__nav-section" data-module="gem-toggle" role="navigation">

    <h2 data-track-count="footerRelatedItemSection" class="gem-c-related-navigation__sub-heading gem-c-related-navigation__sub-heading--footer">Explore the topic</h2>

  <ul data-module="gem-track-click" class="gem-c-related-navigation__link-list">


        <li class="gem-c-related-navigation__link"><a href="/topic/medicines-medical-devices-blood/clinical-trials-investigations" data-track-label="/topic/medicines-medical-devices-blood/clinical-trials-investigations" class="govuk-link govuk-link gem-c-related-navigation__section-link govuk-link gem-c-related-navigation__section-link--footer" data-track-category="relatedLinkClicked" data-track-options="{&quot;dimension28&quot;:&quot;2&quot;,&quot;dimension29&quot;:&quot;Clinical trials and investigations&quot;}" data-track-action="1.1 Explore the topic">Clinical trials and investigations</a></li>
        <li class="gem-c-related-navigation__link"><a data-track-label="/topic/medicines-medical-devices-blood/vigilance-safety-alerts" href="/topic/medicines-medical-devices-blood/vigilance-safety-alerts" class="govuk-link govuk-link gem-c-related-navigation__section-link govuk-link gem-c-related-navigation__section-link--footer" data-track-action="1.2 Explore the topic" data-track-options="{&quot;dimension28&quot;:&quot;2&quot;,&quot;dimension29&quot;:&quot;Vigilance, safety alerts and guidance&quot;}" data-track-category="relatedLinkClicked">Vigilance, safety alerts and guidance</a></li>

  </ul>
</nav>

  </div>

  </div>


    </div>
  </div>


    </main>